ICU Medical Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 ICU Medical Inc 公司

ICU Medical, Inc. 开发、制造和销售用于输液治疗、血管通路和重症监护应用的医疗产品。其产品组合包括门诊、注射器和大容量静脉输液泵和安全软件；专用和非专用静脉输液器、无针静脉输液连接器、外周静脉导管和无菌静脉输液溶液；封闭系统传输设备和药房配制系统；以及一系列呼吸、麻醉、患者监测和温度管理产品。其输液治疗产品包括 Clave 无针产品、Neutron 和 Tego。其肿瘤产品包括 ChemoLock 封闭系统传输设备 (CSTD) 和用于门静脉通路的 Deltec GRIPPER 无芯针。其血管通路产品包括 Safe-T Wing 静脉穿刺和采血设备；Port-A-Cath 植入式端口和 Portex 动脉血液采样注射器。其气管切开产品包括 Portex BLUselect PVC 气管切开插管。

公司简介

公司代码ICUI

公司名称ICU Medical Inc

上市日期Mar 31, 1992

CEOMr. Vivek Jain

员工数量15000

证券类型Ordinary Share

年结日Mar 31

公司地址951 Calle Amanecer

城市SAN CLEMENTE

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编92673-6212

电话19493662183

网址https://www.icumed.com/

公司代码ICUI

上市日期Mar 31, 1992

CEOMr. Vivek Jain

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Vivek Jain

Chairman of the Board, Chief Executive Officer

155.21K

-29.08%

Mr. Brian Michael Bonnell

Chief Financial Officer, Treasurer

30.35K

+21.62%

Mr. Daniel (Dan) Woolson

President

14.19K

+30.63%

Mr. David C. Greenberg, J.D.

Lead Independent Director

8.46K

+16.53%

Mr. Christian B. Voigtlander

Chief Operating Officer

6.09K

+154.83%

Mr. David F. Hoffmeister

Independent Director

4.75K

+56.92%

Ms. Laurie Hernandez

Independent Director

3.61K

+91.41%

Ms. Kolleen T. Kennedy

Independent Director

3.29K

+110.31%

Ms. Elisha W. Finney

Independent Director

3.25K

+52.75%

Mr. Donald M. Abbey

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Vivek Jain

Chairman of the Board, Chief Executive Officer

155.21K

-29.08%

Mr. Brian Michael Bonnell

Chief Financial Officer, Treasurer

30.35K

+21.62%

Mr. Daniel (Dan) Woolson

President

14.19K

+30.63%

Mr. David C. Greenberg, J.D.

Lead Independent Director

8.46K

+16.53%

Mr. Christian B. Voigtlander

Chief Operating Officer

6.09K

+154.83%

Mr. David F. Hoffmeister

Independent Director

4.75K

+56.92%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Consumables

266.23M

44.03%

Vital Care

172.18M

28.47%

Infusion Systems

166.30M

27.50%

地区USD

名称

营收

占比

United States

388.25M

64.20%

EMEA

95.69M

15.82%

Others

61.36M

10.15%

APAC

59.41M

9.82%

业务

地区

业务USD

名称

营收

占比

Consumables

266.23M

44.03%

Vital Care

172.18M

28.47%

Infusion Systems

166.30M

27.50%

股东统计

更新时间: 8月15日周五

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.21%

The Vanguard Group, Inc.

10.75%

Wasatch Global Investors Inc

10.01%

Janus Henderson Investors

10.01%

Fuller & Thaler Asset Management Inc.

5.63%

其他

50.40%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.21%

The Vanguard Group, Inc.

10.75%

Wasatch Global Investors Inc

10.01%

Janus Henderson Investors

10.01%

Fuller & Thaler Asset Management Inc.

5.63%

其他

50.40%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

54.54%

Investment Advisor

46.26%

Hedge Fund

6.89%

Research Firm

2.86%

Corporation

1.90%

Pension Fund

1.46%

Sovereign Wealth Fund

1.18%

Individual Investor

0.98%

Bank and Trust

0.57%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

610

25.98M

105.53%

-2.00M

2025Q1

626

27.13M

110.25%

-2.28M

2024Q4

608

26.46M

107.92%

-3.56M

2024Q3

587

26.75M

109.35%

-2.77M

2024Q2

567

27.24M

111.60%

-1.50M

2024Q1

579

26.01M

106.82%

-1.69M

2023Q4

588

25.74M

106.69%

-1.14M

2023Q3

580

26.53M

109.94%

-1.49M

2023Q2

580

26.62M

110.47%

-2.27M

2023Q1

598

27.04M

112.38%

-1.56M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

3.27M

13.27%

-99.77K

-2.96%

Mar 31, 2025

The Vanguard Group, Inc.

2.64M

10.71%

-39.79K

-1.49%

Mar 31, 2025

Janus Henderson Investors

2.47M

10.03%

+18.73K

+0.76%

Apr 30, 2025

Fuller & Thaler Asset Management Inc.

1.38M

5.62%

-11.46K

-0.82%

Mar 31, 2025

State Street Global Advisors (US)

899.31K

3.65%

-36.99K

-3.95%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

631.48K

2.57%

+91.50K

+16.94%

Mar 31, 2025

Schroder Investment Management North America Inc.

621.95K

2.53%

+122.18K

+24.45%

Mar 31, 2025

Geode Capital Management, L.L.C.

572.31K

2.33%

+25.80K

+4.72%

Mar 31, 2025

持股ETF

更新时间: 9月6日周六

机构名称

占比

Invesco S&P SmallCap Health Care ETF

2.37%

Invesco S&P SmallCap Momentum ETF

0.75%

SPDR S&P 600 Small Cap Growth ETF

0.46%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.46%

iShares S&P Small-Cap 600 Growth ETF

0.43%

VictoryShares US Small Mid Cap Value Momentum ETF

0.32%

SPDR Portfolio Small Cap ETF (SPSM)

0.24%

iShares Core S&P Small-Cap ETF

0.23%

Invesco RAFI US 1500 Small-Mid ETF

0.2%

iShares Russell 2000 Growth ETF

0.15%

Invesco S&P SmallCap Health Care ETF

占比2.37%

Invesco S&P SmallCap Momentum ETF

占比0.75%

SPDR S&P 600 Small Cap Growth ETF

占比0.46%

Vanguard S&P Small-Cap 600 Growth Index Fund

占比0.46%

iShares S&P Small-Cap 600 Growth ETF

占比0.43%

VictoryShares US Small Mid Cap Value Momentum ETF

占比0.32%

SPDR Portfolio Small Cap ETF (SPSM)

占比0.24%

iShares Core S&P Small-Cap ETF

占比0.23%

Invesco RAFI US 1500 Small-Mid ETF

占比0.2%

iShares Russell 2000 Growth ETF

占比0.15%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

ICU Medical Inc

131.710USD

ICU Medical Inc

131.710

概览

公司

财务

分析